← back to search

Brian G. Oliver

University of Technology Sydney · AU
Area of research
Physiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Neonatal Respiratory Health Research, and Air Quality and Health Impacts.
h-index
63
citations
14,365
works
646
NIH funding
primary concept
Medicine
email

Recent publications

Targeted Protein Degradation in Lung Cancer: The Emerging Role of PROTAC Technology and E3 Ligases.
2026cited by 1position: contributordoi
Quality and recommendations of guidelines for multimorbidity and polypharmacy in older adults: A systematic review.
2026cited by 0position: contributordoi
CYFRA 21-1 as a circulating biomarker in non-small cell lung cancer.
2026cited by 0position: contributordoi
The role of plant-derived compounds in anti-obesity drug discovery: A molecular perspective.
2026cited by 0position: contributordoi
Sex and the Developmental Environment Shape Molecular Networks Underlying Bronchial Responsiveness in Mice.
2026cited by 0position: contributordoi
Do microplastics play a role in the pathogenesis of neurodegenerative diseases? Shared pathophysiological pathways for Alzheimer's and Parkinson's disease.
2026cited by 0position: contributordoi
Runx2 Regulated Airway Homeostasis Is Disrupted in Asthma.
2026cited by 0position: contributordoi
Immune Training of the Interleukin 6 Gene in Airway Epithelial Cells is Central to Asthma Exacerbations.
2026cited by 0position: contributordoi
Molecular crosstalk via exosomes in lung cancer progression
Interdisciplinary Medicine 2026cited by 0position: contributordoi
Particulate matter air pollution as a cause of lung cancer: epidemiological and experimental evidence.
2025cited by 19position: contributordoi
Biomimetic multizonal scaffolds for the reconstruction of zonal articular cartilage in chondral and osteochondral defects.
2025cited by 18position: contributordoi
Cellular senescence in chronic obstructive pulmonary disease: Molecular mechanisms and therapeutic interventions.
2025cited by 9position: contributordoi
Cross-Generational Impact of Maternal Exposure to Low Level of PM2.5 on Kidney Health.
2025cited by 5position: contributordoi
Vitronectin regulates lung tissue remodeling and emphysema in chronic obstructive pulmonary disease
Molecular Therapy 2025cited by 5position: contributordoi
Ferroptosis and iron homeostasis in chronic obstructive pulmonary disease: Therapeutic opportunities of iron chelators.
2025cited by 4position: contributordoi
Do microplastics play a role in the pathogenesis of neurodegenerative diseases? Shared pathophysiological pathways for Alzheimer’s and Parkinson’s disease
Molecular and Cellular Biochemistry 2025cited by 3position: middledoi
Caspase-independent cell death in lung cancer: from mechanisms to clinical applications.
2025cited by 3position: contributordoi
Intersecting SARS-CoV-2 spike mutations and global vaccine efficacy against COVID-19.
2025cited by 2position: contributordoi
Analysis of Assessment Methods for Detecting Nicotine Residue and Its Impact on Humans: A Systematic Review.
2025cited by 2position: contributordoi
Exposure to third hand e-cigarette vapour impairs cognitive function in young mice.
2025cited by 2position: contributordoi
Prolonged exposure to low-dose traffic-derived PM<sub>2.5</sub> causes fatty liver disorder in mice.
2025cited by 2position: contributordoi
Developmental air pollution exposure augments airway hyperreactivity, alters transcriptome, and DNA methylation in female adult progeny.
2025cited by 2position: contributordoi
Memory under siege: the cognitive costs of smoking and vaping.
2025cited by 1position: contributordoi
Lunar dust induces minimal pulmonary toxicity compared to Earth dust.
2025cited by 1position: contributordoi
A Novel Regulatory Role for RPS4Y1 in Inflammatory and Fibrotic Processes.
2025cited by 1position: contributordoi
Unravelling the Treatment Strategies for Monkeypox Virus: Success and Bottlenecks.
2025cited by 1position: contributordoi
Dyslipidemia in asthma: Treatable trait, or just a common comorbidity?
2025cited by 0position: contributordoi
Extracellular vesicles in pulmonary diseases: roles and therapeutic potential.
2025cited by 0position: contributordoi
Vitamin C attenuates low-level PM<sub>2.5</sub> exposure-induced lung inflammation and mitochondrial loss.
2025cited by 0position: contributordoi
Evolutionary sex bias in cognitive response to new environmental risk factor - PM2.5.
2025cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Kamal Dua · Western Sydney University74 papers (2020–2026)Hui Chen · Putian University71 papers (2016–2026) · 65 papers (2019–2026)Sachin Kumar Singh · Ganesh Shankar Vidyarthi Memorial Medical College64 papers (2021–2025)Philip M. Hansbro · University of Technology Sydney48 papers (2012–2025) · 24 papers (2019–2026) · 21 papers (2020–2025)Dinesh Kumar Chellappan · Clarivate PLC19 papers (2020–2023)Richard Kim · University of Technology Sydney19 papers (2013–2025) · 18 papers (2021–2025)Keshav Raj Paudel · University of Manchester18 papers (2021–2025) · 18 papers (2021–2025) · 17 papers (2019–2025)Gaurav Gupta · Virginia Commonwealth University14 papers (2021–2024)Sonia Saad · Royal North Shore Hospital14 papers (2019–2025)Gang Liu · Hebei Medical University12 papers (2019–2025)Maarten Van den Berge · Ghent University Hospital12 papers (2019–2026)Niraj Kumar Jha · Directorate of Medicinal and Aromatic Plants Research11 papers (2021–2023)Keshav Raj Paudel · Mokpo National University11 papers (2021–2024)Min Xie · Shandong University of Traditional Chinese Medicine10 papers (2020–2024)